Empfehlungen zur Prophylaxe der Nebenwirkungen bei intravasaler Applikation jodhaltiger Kontrastmittel

Thomsen, 2003, Guidelines for contrast media from the European Society of Urogenital Radiology, Am J Roentgenol, 81, 1463, 10.2214/ajr.181.6.1811463 Thomsen, 2003, Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines, Br J Radiol, 76, 513, 10.1259/bjr/26964464 Nash, 2002, Hospital-acquired renal insufficiency, Am J Kidney Diseases, 39, 930, 10.1053/ajkd.2002.32766 Lin, 2005, Prevention of radiocontrast nephropathy, Curr Opin Nephrol Hypertension, 14, 105, 10.1097/00041552-200503000-00004 Morcos, 1998, Contrast media-induced nephrotoxicity—questions and answers, Br J Radiol, 71, 357, 10.1259/bjr.71.844.9659127 Uder, 2002, cAMP and cGMP do not mediate the vasorelaxation induced by iodinated radiographic contrast media in isolated swine renal arteries, Acta Radiol, 43, 104, 10.1080/028418502127347547 Heinrich, 2004, Effects of dimeric radiographic contrast medium iotrolan on Swine renal arteries: comparison with monomeric contrast media iohexol and iomeprol, Invest Radiol, 39, 406, 10.1097/01.rli.0000129471.63758.88 Heinrich, 2005, Cytotoxic effects of ionic high-osmolar, nonionic monomeric, and nonionic iso-osmolar dimeric iodinated contrast media on renal tubular cells in vitro, Radiology, 235, 843, 10.1148/radiol.2353040726 Heinrich, 2005, Pathogenesis of contrast-induced nephropathy, Am J Roentgenol, 185, 1079, 10.2214/AJR.05.5136 Uder, 2006, Vascular reactions of iodinated X-ray contrast media: mechanisms and possible therapeutic interventions, Anti-Inflammatory Anti-Allergy Agents Med Chem, 5, 129, 10.2174/187152306776872497 Heinrich, 2007, Reversibility and time-dependency of contrast medium induced inhibition of MTT-conversion in renal proximal tubular cells in vitro: comparison of a monomeric and a dimeric nonionic iodinated contrast medium, Invest Radiol, 42, 732, 10.1097/RLI.0b013e3180ebe6a2 Cockcroft, 1976, Prediction of creatinine clearance from serum creatinine, Nephron, 16, 31, 10.1159/000180580 Levey, 1999, A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group, Ann Intern Med, 130, 461, 10.7326/0003-4819-130-6-199903160-00002 Heinrich, 2006, Hydrierung zur Prävention der kontrastmittel-induzierten Nephropathie: Ein Update, RöFo, 178, 378 Hoffmann, 2004, The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable, J Am Soc Nephrol, 15, 407, 10.1097/01.ASN.0000106780.14856.55 Trivedi, 2003, A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity, Nephron Clin Pract, 93, C29, 10.1159/000066641 Mueller, 2002, Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty, Arch Intern Med, 162, 329, 10.1001/archinte.162.3.329 Bader, 2004, What is the best hydration regimen to prevent contrast media-induced nephrotoxicity?, Clin Nephrol, 62, 1, 10.5414/CNP62001 Krasuski, 2003, Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study, J Invasive Cardiol, 15, 699 Taylor, 1998, PREPARED: preparation for angiography in renal dysfunction: a randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction, Chest, 114, 1570, 10.1378/chest.114.6.1570 Heinrich, 2007, Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: in vitro study, Radiology, 242, 425, 10.1148/radiol.2422060245 Heinrich, 2007, Nephrogene systemische Fibrose nach Anwendung gadoliniumhaltiger Kontrastmittel – Ein Statuspapier zum aktuellen Stand des Wissens, RöFo, 179, 613 Thomsen, 1999, Contrast media and metformin: guidelines to diminish the risk of lactic acidosis in non-insulin-dependent diabetics after administration of contrast media. ESUR Contrast Media Safety Committee, Eur Radiol, 9, 738, 10.1007/s003300050746 Sirtori, 1994, Re-evaluation of a biguanide, metformin: mechanism of action and tolerability, Pharmacol Res, 30, 187, 10.1016/1043-6618(94)80104-5 McCartney, 1999, Metformin and contrast media – a dangerous combination?, Clin Radiol, 54, 29, 10.1016/S0009-9260(99)91236-9 ESUR guideline on contrast media version 6.0. 〈www.esur.org/ESUR_Guidelines_New.6.0.html〉. Rendl, 2001, Schilddrüse und Röntgenkontrastmittel: Pathophysiologie, Häufigkeit und Prophylaxe der jodinduzierten Hyperthyreose, Deutsches Ärzteblatt, 98, A402 Hintze, 1999, Risk of iodine-induced thyrotoxicosis after coronary angiography: an investigation in 788 unselected subjects, Eur J Endocrinol, 140, 264, 10.1530/eje.0.1400264 Nolte, 1996, Prophylactic application of thyrostatic drugs during excessive iodine exposure in euthyroid patients with thyroid autonomy: a randomized study, Eur J Endocrinol, 134, 337, 10.1530/eje.0.1340337 de Bruin, 1994, Iodide-induced hyperthyroidism with computed tomography contrast fluids, Lancet, 343, 1160, 10.1016/S0140-6736(94)90265-8 Schumm-Draeger, 1989, Effekt einer thyreostatischen Therapie bei iodinduzierter Hyperthyreose – Untersuchungen an xenotransplantierten Geweben immunogener sowie nichtimmunogener Hyperthyreoseformen, 253 Meyer-Gessner, 1989, Nebenwirkungen der antithyreoidalen Therapie der Hyperthyreose, Deutsche Medizinische Wochenschrift, 114, 166, 10.1055/s-2008-1066570 Ring, 1999, Anaphylaxis and anaphylactoid reactions. Classification and Pathophysiology, Clin Rev Allergy Immunol, 17, 387, 10.1007/BF02737644 Christiansen, 2005, X-ray contrast media – an overview, Toxicology, 209, 185, 10.1016/j.tox.2004.12.020 Idee, 2005, Allergy-like reactions to iodinated contrast agents. A critical analysis, Fundam Clin Pharmacol, 19, 263, 10.1111/j.1472-8206.2005.00326.x Morcos, 2005, Review article: acute serious and fatal reactions to contrast media: our current understanding, Br J Radiol, 78, 686, 10.1259/bjr/26301414 Laroche, 1998, Mechanisms of severe, immediate reactions to iodinated contrast material, Radiology, 209, 183, 10.1148/radiology.209.1.9769830 Eloy, 1991, Contrast media for angiography: physicochemical properties, pharmacokinetics and biocompatibility, Clin Mater, 7, 89, 10.1016/0267-6605(91)90045-H Ansell, 1996, Complications of intravascular iodinated contrast media, 245 Walker, 1986, Reactions to radiographic contrast media: an attempt to detect specific anti-contrast medium antibodies in the sera of reactor patients, Br J Radiol, 59, 531, 10.1259/0007-1285-59-702-531 Lasser, 1987, Pretreatment with corticosteroids to alleviate reactions to intravenous contrast material, New Engl J Med, 317, 845, 10.1056/NEJM198710013171401 Lasser, 1994, Pretreatment with corticosteroids to prevent adverse reactions to non-ionic contrast media, Am J Roentgenol, 162, 523, 10.2214/ajr.162.3.8109489 Bettmann, 2004, Frequently asked questions: iodinated contrast agenst, Radiographics, 24, S3, 10.1148/rg.24si045519